matthew thompson

New Ivermectin Dose for COVID-19 Could Bring Relief to Sufferers

After waiting for more than 10 years, patients suffering from viral cardiomyopathy have finally been given the opportunity to try out a new Ivermectin 12 mg dose. The previous dose of this antiparasitic drug was not suitable for treating cardiomyopathy, however, and thus, it was not used by doctors. It has now been approved for use in patients with cardiomyopathy caused by coxsackievirus B 19 (COVID-19). This development has brought relief to thousands of people in the United States alone who suffer from this condition every year. F ollow given link to buy directly buy ivermectin for humans https://medzpills.com/product/ivermectin-12mg/